The Urinary Excretion of Metabolites During Radiological Cell-Destruction in Leukaemic Patients by Gerbrandy, J. et al.
275
THE URINARY EXCRETION OF METABOLITES DURING
RADIOLOGICAL CELL-DESTRUCTION IN LEUKAEMIC PATIENTS
J. GERBRANDY, H. B. A. HELLENDOORN AND H. LOKKERBOL
From the Medical and Radiological Department8 ofthe Antoni van Leeuwenhoek-Huis,
Netherland8 Cancer Institute, Amsterdam
Received for publication January 25, 1958
IN the literature it has been shown that in cancer patients metabolic changes
occur during irradiation or treatment with cytotoxic drugs (Eliel et al., 1950;
Homburger, Bonner and Fishman, 1952; Fenninger, Waterhouse and Kentmann,
1953; Spencer, Greenberg andLaszlo, 1954; Sandberg, Cartwright andWintrobe,
1956; Krakoff, 1957).
The disappearance of tumour tissue will be accompanied by an increased
excretion of metabolites derived from this tissue, unless the utilization ofthese
metabolites in other tissues is accelerated. This means, iftumour tissue disappears
during radiological or chemical treatment the urinary excretion of the quanti-
tatively most important cell metabolites (phosphate, nucleic acids, potassium and
nitrogen) will probably be increased. In that case the duration and the extent of
the increase of excretion of metabolites will depend on the amount of tumour
loss and on the rate of tumour destruction. The most marked metabolic effect
can be expected in leukaemic patients since during radiological or chemothera-
peutical treatment enormous amounts of tumour tissue can disappear in a short
time. In fact, the metabolic changes will probably reflect the rate of cell destruc-
tion and the total amount of tumour loss, provided the different metabolites are
not utilized in other tissues. The urinary excretion ofthe above-mentioned meta-
bolites were therefore investigated for periods of 25 to 50 days duringradiological
treatment of5leukaemic patients and 3 cancerpatientswhowereonastandardized
diet. In these experiments a quantitative relationship is shown betweenthe total
loss oftumour tissue and the excess excretion ofthe metabolities.
METHODS
Two patientswith chronicmyeloidleukaemia, 3 patientswithchroniclymphoid
leukaemia, 2 patients with metastasized carcinoma and 1 patient with meta-
stasized reticulosarcoma received an accurately standardized diet of 2000-2500
calories a day, which was poor in protein, purines and calcium. The average
uptake amounted to 600 mg. P, 40 mM K, 200 mg. Ca and 3000 mg. N a day.
The following determinations were made on the 24-hours urine: creatinine
by means of the method of Jaff6, modified by De Vries and Van Daatselaar
(1955); urea according to a micro-aeration method with urease; calcium by a
photometrically performed micro-titration with EDTA (Complexon III) using
murexide as an indicator; sodium and potassium by flame photometry; uric
acid according to the method ofFolin, modified by De Vries and Van Daatselaar
(1955); inorganic phosphate with molybdic acid. All these methods are described
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in order to check that no urine had been accidentally discarded during the day.
The above-mentioned components were also measured in the serum ofthe patients
once a week. The rectal temperature was taken three times a day; the course
of the rectal temperature in the graphs represents the highest readings of each
day. Thebodyweightwas measuredexactlyatthesame time ofthe day and in the
same conditions three times a week.
In 2 leukaemic patients and in the 2 patients with metastasized carcinoma
the faecal excretion of nitrogen, phosphate and calcium was investigated.
All the patients received X-ray irradiation; the 5 leukaemic patients received
irradiation of the spleen with a total skin dose between 550 and 1475 r (240 kV,
0*85 mm. Cu + 1 mm. Al, FS distance 50 cm.). Mrs. B-, with metastasized
mammary carcinoma, received a total tumour dose of 3200 r (overall time 22
days) on a presternal metastasis. Mrs. 0- received about 2500 r in 29 days
(4 fields, beam directed) on a vaginal metastasis from an operated corpus uteri
carcinoma. Mr. Gl- received a tumour dose of about 2500 r in 22 days on a
mediastinal metastasis from a reticulum-cell sarcoma of the nose. The X-ray
irradiation was only started ifa reasonably stabilized level ofexcreted metabolites
had beenreached. Onlyin the firstleukaemicpatient, Mr. de V-, didthe pretreat-
ment period have to be curtailed, because this patient produced signs ofa transient
aphasia probably caused by cerebral leukaemic infiltrations. In 2 leukaemic
patients it was possible to continue the observation time long enough to reach a
stabilized post-irradiation excretion.
RESULTS
In five leukaemic patients (2 with chronic myeloid leukaemia and 3 with
chronic lymphoid leukaemia) the spleen was irradiated and in three cancer
patients metastasized tumours were irradiated with X-rays (see Methods). In
the leukaemic patients the number of leucocytes fell to a much lower level and
the spleen and liver appreciably decreased in size. In the 2 patients with meta-
stasized carcinoma no measurable decrease of tumour tissue could be observed,
but in the patient withreticulum cell sarcoma a marked decrease ofthe mediastinal
swelling was seen. In Table I the figures are given of the changes of the urinary
excretion ofphosphate, uric acid, potassium, sodium, calcium, urea and creatinine.
The column " metabolic changes during treatment " comprises the period of
treatment together with the next period of increased excretion of metabolites.
In the first 2 cases the time ofinvestigation was prolonged till a new equilibrium
could be observed; this is called " period of stabilization ". In Mr. P- nearly
the whole period of metabolic change was observed; in 3 patients (Mrs. Z-,
Mrs. v. D- andMr. GI-) thelargestpart ofthisperiodhas beentakeninto account
In Fig. 1 the figures of our 5 leukaemic patients are graphically shown. It
appeared that a decrease in the leucocyte count and in the spleen size was accom-
panied by a rise of excretion of cellular metabolites, namely phosphate, uric
acid, potassium and urea. The creatinine excretion was not affected in the same
way but gradually declined. In all our patientsthe bodyweightfellalso gradually.
In 2 leukaemic patients (Mrs. M- and Mrs. v. D-) and in 2 cancer patients
(Mrs. Br- and Mrs. O-) the faecal excretion of nitrogen, phosphate and calcium
was determined. No appreciable changes of phosphate excretion were demon-
strable and only small changes of nitrogen and calcium excretion were visible.EXCRETION OF METABOLITES
Therefore, as far as can be deduced from these facts, the rise ofurinary excretion
of metabolites is caused by an increased production.
In the next paragraphs the following 3 relationships will be established:
(1) A time-relationship between loss of tumour tissue and rise of the
excretion of metabolites;
(2) a relationship between the estimated loss of tumour tissue and the
total excess excretion of phosphate;
(3) a mutual relationship between the total excess excretions ofdifferent
metabolites.
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FIG. 1.-Changes of the urinary excretion of metabolites in 5 leukaemic patients during
X-ray irradiation of the spleen.
(1) Time-relation8hip
A close time-relationship appeared to exist in the leukaemic patients between
the onset and termination of the rise of excreted metabolites and the onset and
termination of the fall of leucocytes. In 4 patients the phosphate and uric acid
excretion started to rise on the second day ofthe irradiation to the spleen; in the
5th patient (Mrs. M-) both started to rise on the first day. The percentage rise of
the potassium and urea is smaller as compared with the phosphate and uric
acid; the onset of rise therefore is more difficult to establish. The same pattern
may be seen at the termination ofthe rise ofmetabolite-excretion. In Mr. de V-,
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Mrs. M- and Mr. P- the phosphate excretion returned to the pre-treatment
level, when the amount of leucocytes stabilized at 22,000, 5,500 and 15,000
respectively. The phosphate and uric acid excretion of Mrs. Z- and Mrs. v. D-
still remained at an elevated level at the end of the observation period, but in
both patients the fall ofleucocytes continued (Fig. 1). In Mrs. Z- the leucocytes
fell from 100,000 to 40,000 per mm.3 during thefollowing 10 days after the end of
the observation and in Mrs. v. D- the leucocytes fell from 80,000 to 50,000 per
mm.3 during the following 4 days; 14 days later a level of 20,000 had been
reached.
(2) The total excess-excretion ofphosphate
According to Waterhouse, Terepka and Sherman (1955) and Rigas et al.,
(1956) 1 kg. of myeloid leukaemia cells contains about 3-3 g. of P and 1 kg. of
lymphatic leukaemia cells contains about 4-7 g. of P. If the excess excretion of
phosphate in the urine during the period of treatment is an index of the total
mass oflost leukaemic tissue, this total volume can be estimated in our patients.
In Table II the total excess excretions ofphosphate during treatment as compared
to the control period before treatment is calculated. From these figures the total
volume oflost tumour cells in every patient was thus calculated. The phosphate
content of the reticulum cell sarcomna was assumed to be similar to that of a
lymphatic leukaemia.
IABLE II
Excess excretion of P in the Calculated loss
urine during period of of leukaemic
metabolic changes cells
Patients Diagnosis (mg.) (kg.)
Mr. de V- . Myel. leuk. . (Total period) 13
- 800 . 4*2
Mrs. M- .- ,, . , , 8-500 . 2-6
Mrs. Z- . Lymph. leuk. . (Largest part of period) 6v700 . 14
Mrs. v.D . ,, . , ,, , ,, 6-300 . 1-3
Mr. P . , (Nearly total period) 2-800 . 0-6
Mr. G1- . Retic. sarc. . (Largest part of period) 2 200 . 0 5
In the leukaemic patients the total loss of tumour cells from the body can
roughly be estimated by the disappearance ofleukaemic cells from the peripheral
blood and the decrease in size of the spleen, liver and lymph nodes. Mr. de V-
had, during the control period, about 600,000 myeloid leucocytes per mm.3 in
his peripheral blood and a hematocrit ofwhite cells of37 vol. per cent. In accord-
ance with the increased blood volume in patients with essential polycythaemia
the blood volume inthis patient willbelarger than normal. In Table III the estim-
ated blood volume and the roughly estimated decrease ofthe volume ofleucocytes
of the peripheral blood are given. The estimated loss of leucocytes calculated
from the excess excretion of phosphate is compared with the estimated loss of
leucocytes from the peripheral blood. It appears that the decrease in the volumes
of the spleen and liver sufficiently accounts for the difference between these two
calculated volumes. In the 3 patients with lymphatic leukaemia only moderate
enlargements and decreases of lymph nodes were observed. The decrease of
mediastinal swelling in the patient with reticulo sarcoma (Mr. GI-) might well
amount to about halfakilogram. Therefore thetotalexcess excretionofphosphate
agrees satisfactorily with the estimated loss oftumour tissue.EXCRETION OF METABOLITES
TABLE III
Dia
Mye
Lymp
Rel. cell
volume
of
leucocytes
6gnosis (vol. %)
1. leuk. . 37
,,9 . 18
)h. leuk. . 15
, .JI 9
,, . 3
Estimated
blood
volume
(litre)
7
6
5
5
5
Decrease
of leuc.
in
1000'mm.3
600-÷ 20
250--.5
600-+100
350-*80
120-.15
Estimated
loss of
leucocytes
(kg.)
2-6
1-1
0-8
0 5
0-2
Loss
of leuc.
calculated
from
excess
excretion
(kg.)
4-2
2-6
1-4
1-3
0 6
Diff.
(kg.)
1*6
1-5
0-6
0-4
0f4
Organs palpable
in cm. below
costal margin
-
Spleen Liver
23-+10 11-*5
25- 18 8--.6
24-÷ 17 14--10
16-+12 6-+1
3-*j 4--*1
(3) The mutual ratio between the excess excretions ofmetabolites
In Table IV the total excess excretions of metabolites in the urine during the
period of metabolic changes is calculated in grams and millimols. The level of
the "metabolic changes during treatment " inthe patientswith myeloidleukaemia
is compared with the level ofthe " period ofstabilization", because especiallythe
levels of uric acid and urea excretion in the " control period " were abnormally
high. In the literature (see Discussion) the ratios between the different metabolites
in tumour tissue in vitro have been described. It seemed therefore interesting to
calculate the following ratios from the excess excretions in our experiments:
Mol P: mol uric acid, mol P: mol K, mol K: gram N (calculated from urea +
uric acid + creatinine), mol urea: mol uric acid, gram N (from urea + uric
acid + creatinine) gram P. The changes of calcium excretion were too insig-
nificant to make corrections in the phosphate excretion necessary. The ratios
mol P: mol uric acid and mol P: mol K appeared to be in reasonable agreement
with the expected ratios; the calculated excess excretion of N however, was too
low.
TABLE IV.-Excess Excretion of Metabolites in the Urine During the Period of
Metabolic Changes
Phosphate
(gram) (mMol)
13 80 445
8 45 273
6 73 217
6 27 202
2 82 91
2-16 70
Uric acid
(gram) (mMol)
36 00 213
14 40 86
8-50 51
6-68 40
5-63 34
2-30 14
Potassium
(gram) (mMol)
420
- 194
209
_ 320
188
144
Sodium
(gram) (mMol)
- 267
- -148
- 88
291
-32
- -296
Urea
(gram) (mMol)
189 0 3150
62*9 1050
19 7 328
53-3 887
13*1 218
10-6 177
Creatinine
.
(gram) (mMol)
-3 13 -
-1 22 -
-1 99
-2-21 -
-1-35
-1.25
N (urea + uric acid
+ creatinine)
(gram) (mMol)
99.0 -
33.7
11 -2
26-2
7-4
6-2 -
Patients
Mr. de V- .
Mrs. M-
Mrs. Z
Mrs. v. D-.
Mr. P-
Patients
Mr. de V-
Mrs. M-
Mrs. Z
Mrs. v. D-
Mr. P-
Mr. Gl-
Patients
Mr. de V-
Mrs. M-
Mrs. Z-
Mrs. v. D
Mr. P- .
Mr. Gl-
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TABLE V.-Excess Excretion of Metabolites in the Urine During Metabolic Changes
MolP:mol Mol P: Mol K: Urea rUrea
Patients Diagnosis uric acid Mol K Gram N1 Uric acid Mol urea: mol Gram N: Uric acid PCreatinine uric acid Gram P LCreatinine
Mr. de V-. Myel. leuk. . 2.1 . 11 . 42 . 148 . 7 2
MArs. M- . , . 3-2 . 1-4 . 58 . 12-2 . 40
Mrs. Z- . Lymph. leuk. . 43 . 10 . 18-7 . 6-4 . 1-7
Mrs. v. D- ,, . 50 . 0-6 . 12-2 . 22-2 . 4-2
Mr.P . ,, . 2 7 . 0 5 . 25*4 . 64 . 26
Mr. G1- . Retic. sarc. . 50 . 0.5 23*2 . 126 . 2-9
CONCLUSIONS AND DISCUSSIONS
The excess excretion of phosphate during a low-protein standardized diet
seems to be arough quantitative measure oftumour destruction in ourexperiments.
The following 6 points are evidence for this conclusion:
1. In the 4 patients in whom the faecal excretion was measured during X-ray
irradiation the faecal excretion of phosphate did not rise.
2. In the 5 leukaemic patients a close relationship appeared to exist between
the onset ofthe rise ofmetabolites excretion and the commencement ofirradiation
(usually a difference ofa day) and between the end ofthe increases ofmetabolites
excretion and the stabilization ofthe amount ofleucocytes on a much lower level.
3. The total volume ofexcess excretion ofphosphate agreed within reasonable
limits with the clinical estimation oftotal tumour loss in the 5 leukaemic patients.
4. In 2 of the 3 non-leukaemic cases no measurable decrease of tumour tissue
could be found after a much larger dose of X-ray irradiation; in these 2 cases
the irradiation was not followed by a rise ofexcretion ofmetabolites. In the third
patient with metastasized reticulo sarcoma a visible decrease of tumour-mass
was accompanied by a rise of excretion of metabolites similar to that in the
leukaemic patients.
5. A close parallel exists between the rise and fall ofthe excretion ofphosphate
and ofthe other cellular metabolites such as uric acid, urea and potassium.
6. The ratios between the total excess excretions of phosphate, uric acid and
potassium are in the range as might be expected from the destruction of tumour
tissue (see below).
The ratio between the excess excretion of mol P and mol K appeared to vary
between 0 5 and 1*4. This is in reasonable accordance with the findings ofWater-
house, Terepka and Sherman (1955) who foundthis ratio to be about 1-0 in biopsies
ofmalignant tissue. Also the ratio between mol P and mol uric acid in the excess
excretion is in reasonable accordance with other findings. The phosphate and
uric acid originating from the destruction of nucleic acids will be excreted in a
ratio mol P: mol uric acid ofabout 2 as the pyrimidine nucleus is not metabolized
in uric acid. However, in leukaemic leucocytes about 30-50 per cent of the total
P-content is derived from other compounds than nucleic acids (Rigas et al., 1956)
therefore a ratio mol P : mol uric acid between 3 and 4 had to be expected. In
fact we found this ratio varying between 2*1 and 5-0. The ratio between gram N
and gram P varies in our experiments between 1*8 and 7-3; WVaterhouse et al.,
(1955) calculated this ratio in leukaemic cells to be between bi6 and 7-9. Our
calculated excess excretion of nitrogen from urea, uric acid and creatinine,EXCRETION OF METABOLITES
constitutes a good 90 per cent ofthe total nitrogen excretion. Probably, however,
in our cases the caloric intake was too small; in normal cases 2000 calories per
day suffices for a caloric equilibrium, but in feverish or tumour patients this
might be insufficient. Therefore a retention of urea together with P in a high
N: P ratio seems to be a possible explanation for our low figures. If this is true
the total amount ofP, derived from the breakdown oftumour tissue is larger than
the excess excretions of P calculated by us. Our figures ofthe ratio mol K: gram
N and of the ratio mol urea: mol uric acid are too inconsistent to allow any
conclusions to be drawn.
The gradual fall of creatinine was accompanied by a fall of the creatinine
content of the serum (loss of body weight ?). The calcium excretion in our leuk-
aemic patients is remarkably low. Maybe this has something to do with the
altered phosphate-metabolism. Anyway, in all the 5 patients the low calcium
excretion fell even to a still lower level during the rise of phosphate excretion
(Fig. 1). The excretion of uric acid often rises above the solubility of urates,
especially because this solubility is decreased in an acid environment. Our first
patient with myeloid leukaemia, Mr. de V-, had ureteric colics at the height of
the uric acid excretion from urate stones. The pH of his urine at that time was
4.9. Actually, in these circumstances alkalines and extra fluid ought to be given
to these patients.
Assuming that the X-ray irradiation of the spleen inhibits the formation of
new leukaemic cells the patterns of excretion of phosphLate and uric acid seem
to agree with the known fact about the metabolism of these substances. Presum-
ably the phosphate originating from an elevated turnover ofleucocytes is wholly
re-utilized. Immediately after commencing irradiation ofthe spleen the phosphate
excretion starts to rise because the re-utilization of phosphate in new leukaemic
cells has been made impossible. It is well known on the other hand that uric
acid is excreted in many untreated patients with myeloid leukaemia in larger
amounts than normal. This is also seen in our 2 patients. Uric acid derived from
the breakdown of nucleic acids therefore seems to be non- or only partially
re-utilizable. In this respect the phosphate and uric acid closely resemble the iron
and urobilinogen respectively derived from the breakdown of haemoglobin. If
the hypothesis that the irradiation of the spleen only stops theformation of new
leukaemic cells is correct-X-rays do indeed inhibit the mitotic activity of cells-
the total duration ofthe elevated excretion ofcell metabolites reflects to a certain
extent the lifetime ofthe total population ofleukaemic cells.
SUMMARY
In 5 leukaemic and 3 cancer patients, who were on a standardized low-protein
diet, the urinary excretion of phosphate, uric acid, potassium, calcium, urea and
creatinine was investigated during X-ray treatment. During this disappearance
of tumour tissue the urinary excretion of cell metabolites rose. The excess excre-
tion ofurinary phosphate appeared to be aroughly quantitative measure oftumour
loss. This conclusion is based on the following observations:
1. In 4 patients in whom the faecal excretion was measured during irradiation,
no rise of phosphate excretion was observed.
2. A close time-relationship existed between the onset of the rise ofthe excre-
tion ofmetabolites andthe commencement ofX-rayirradiation (usually adifference
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of one day) and between the end of the increased excretion ofmetabolites and the
stabilization of the amount of leucocytes on a lower level.
3. The total volume ofexcess excretion ofphosphate agreed within reasonable
limits with the clinical estimation oftotal tumour loss in the leukaemic patients.
4. In 2 of the 3 cancer patients no decrease of tumour tissue was observed
after a much larger dose of X-ray irradiation and no rise of excretion of meta-
bolites was seen; in the third patient vwth metastasized reticulo sarcoma a visible
decrease of tumour mass was accompanied by a rise of excretion of metabolites
similar to that in the leukaemic patients.
5. A close parallel existed between the rise and fall of the excretion of cell
metabolites such as phosphate, uric acid, potassium and urea.
6. The ratios between the total excess excretions of phosphate and potassium
and of phosphate and uric acid appeared to be in the range as could be expected
from the destruction oftumour tissue.
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